25,000 people begin taking Wegovy each week, but Novo Nordisk stock is sinking anyway

Get the Full StoryWhile sales of the blockbuster drug nearly doubled, the results still fell short of analysts expectations as the company faces competition from Eli Lilly.

Danish drugmaker Novo Nordisk, the creator of Ozempic and Wegovy, announced a shocking statistic Thursday: Over 25,000 people begin Wegovy each week. The number is five times larger than the numbers from December about 5,000 new users a week.

Share:

More in Business...

This 1,250 status trash can is also an avant-garde piece of art

4 tricks venture capitalists use to make meetings better

A business psychologist explains how these 7 harmful myths about resilience are holding you back

Is the self-driving dream going to crash into a regulatory wall?

Now is the time for corporations to eradicate silencing mechanisms in the workplace